|
|
Article: Hoffman-La Roche offers to acquire Sterling Drug Inc. for $72 per share.
- Article from:
- PR Newswire
- Article date:
- January 4, 1988
CopyrightCOPYRIGHT 1988 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HOFFMAN-LA ROCHE OFFERS TO ACQUIRE STERLING DRUG INC.
FOR $72 PER SHARE
NEW YORK, Jan. 4 /PRNewswire/ -- Fritz Gerber, chairman and chief executive officer of Hoffmann-La Roche announced today that the following letter had been sent to John M. Pietruski, chairman and chief executive officer of Sterling Drug Inc.
F. Hoffmann-La Roche and Company is a leading worldwide pharmaceutical company whose primary focus is prescription medicines, with emphasis on anti-infectives, dermatologicals, cardiovasculars, anti-inflammatories and biotechnologically derived products and products for the treatment of the central nervous system. ...